Meningioma Symposium 2026 Rome · 28 Sept
Back to symposium

Imprint & Privacy Policy

Imprint

Wiener Medizinische Akademie GmbH (WMA)
Alser Straße 4 / Uni Campus Altes AKH, Hof 1 / Gebäude 1.17
1090 Vienna, Austria
Phone: +43 1 405 1383
Email: meningiomasymposium@wma.co.at
Web: www.wma.co.at

UID: ATU44511907
Italian VAT No.: IT00375259991
Firmenbuchnummer: FN 168190 p
Firmenbuchgericht: Handelsgericht Wien
Geschäftsführung: Jerome del Picchia, Mirjam Uebelhör

Terms & Conditions — Meningioma Symposium 2026 — General Terms & Conditions

Organisation & Registration

Phone: +43 1 405 1383 42
Email: meningiomasymposium@wma.co.at

Exhibition & Sponsoring

Phone: +43 1 405 1383 42
Email: meningiomasymposium@wma.co.at


Privacy Policy (EU-GDPR)

Personal Data Collection

The academy collects personal information through online forms solely for organising the symposium. Data is shared with third parties only when necessary for event operations (hotels, transport, organisers).

Photography & Recording

Registrants grant permission for official photographs and films to be used for marketing purposes indefinitely. Participants may opt out by contacting dataprotection@medacad.org.

Data Controller

Wiener Medizinische Akademie
Alser Straße 4, 1090 Vienna, Austria
Phone: +43 1 405 1383 42
Email: dataprotection@medacad.org
Management: Mirjam Uebelhör, Jerome del Picchia
Data Protection Coordinator: Nikolett Horvath

Data Retention

  • Sensitive data and passport information: deleted after event conclusion
  • All other data: retained for 7 years per Austrian VAT regulations
  • Upon consent withdrawal: immediate deletion

Data Subject Rights

Participants have rights including access, rectification, erasure, data portability, and the ability to lodge complaints with supervisory authorities.

Third-Party Transfers

Data transfers to USA-based services (Oasis abstract software, Mailchimp) include standard data protection clauses per GDPR requirements.

Legal Basis for Processing

Personal data is processed on the basis of Art. 6(1)(b) GDPR (performance of a contract / pre-contractual measures) for registration and event organisation, and Art. 6(1)(f) GDPR (legitimate interests) for communication and event documentation purposes.

Supervisory Authority

You have the right to lodge a complaint with the competent data protection authority:
Österreichische Datenschutzbehörde
Barichgasse 40–42, 1030 Vienna, Austria
www.dsb.gv.at

Hosting & Technical Operation

This website is operated and hosted by Wiener Medizinische Akademie GmbH, Alser Straße 4, 1090 Vienna, Austria. No personal data is collected through this website beyond standard server log files (IP address, browser type, date/time of access), which are automatically deleted after 7 days.

AIFA Mandatory Procedure for Pharmaceutical Companies

Any Italian or foreign pharmaceutical company that holds a marketing authorisation in Italy (AIC), or that markets medicines in Italy on the basis of an agreement with the respective marketing authorisation holder, and that intends to organise or contribute to the organisation of a congress, conference or meeting on topics related to the use of medicines, must submit a communication request to the Italian Medicines Agency (AIFA). This request is required in order to obtain authorisation for the proposed educational meeting and to allow the Agency to verify its strictly technical-scientific nature, pursuant to Article 124 of Legislative Decree 219/2006.

Further information is available here: www.aifa.gov.it/en/ACC/

 

The Italian agency officially appointed to manage the AIFA procedure for the EANO Meeting is:
Fargo International di Giulia Cambria
Via Pietro Maroncelli, 32
50137 Firenze – Italy
VAT No. 07325650484
Email: info@fargointernational.it

 

Please note the mandatory deadlines for the AIFA submission:

  • First mandatory deadline (70 days prior to the start of the congress): July 18th, 2026
  • Second and final mandatory deadline (60 days prior to the start of the congress): July 28th, 2026
© 2026 Meningioma Symposium Rome · 28 September 2026